Current issues in immunomodulatory treatment of multiple sclerosis - A practical approach

被引：6
|
作者：
Stangel, M
Gold, R
Gass, A
Haas, J
Jung, S
Elias, W
Zettl, UK
机构：
[1] Hannover Med Sch, Dept Neurol, D-30625 Hannover, Germany
[2] Univ Gottingen, Inst MS Res, D-3400 Gottingen, Germany
[3] Univ Basel, Dept Neurol, CH-4003 Basel, Switzerland
[4] Univ Saarland, Dept Neurol, Homburg, Germany
[5] Univ Rostock, Dept Neurol, D-2500 Rostock 1, Germany
来源：
JOURNAL OF NEUROLOGY | 2006年 / 253卷 / Suppl 1期
关键词：
D O I：
10.1007/s00415-006-1108-9
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：32 / 36
页数：5
相关论文
共 50 条
  • [31] Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations
    Wiendl, H.
    Toyka, K. V.
    Rieckmann, P.
    Gold, R.
    Hartung, H. -P.
    Hohlfeld, R.
    JOURNAL OF NEUROLOGY, 2008, 255 (10) : 1449 - 1463
  • [32] Stress regulation in multiple sclerosis - current issues and concepts
    Heesen, C.
    Mohr, D. C.
    Huitinga, I.
    Bergh, F. Then
    Gaab, J.
    Otte, C.
    Gold, S. M.
    MULTIPLE SCLEROSIS JOURNAL, 2007, 13 (02) : 143 - 148
  • [33] New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimode
    Samuel, Komoly
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2012, 65 (11-12): : 421 - 422
  • [34] Immunomodulatory treatment of multiple sclerosis in Denmark: a prospective nationwide survey
    Sorensen, PS
    Koch-Henriksen, N
    Ravnborg, M
    Frederiksen, JL
    Jensen, K
    Heltberg, A
    Schaldemose, H
    Deth, S
    Kristensen, O
    Worm, M
    Stenager, E
    Hansen, HJ
    Sivertsen, B
    Torring, J
    MULTIPLE SCLEROSIS, 2006, 12 (03): : 253 - 264
  • [35] Autoimmune hepatitis in patients with multiple sclerosis: The role of immunomodulatory treatment
    Rigopoulou, Eirini, I
    Gyftaki, Sofia
    Arvaniti, Pinelopi
    Tsimourtou, Vana
    Koukoulis, George K.
    Hadjigeorgiou, Georgios
    Dalekos, George N.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2019, 43 (03) : E25 - E32
  • [36] IS SECOND-LINE IMMUNOMODULATORY TREATMENT EFFECTIVE IN MULTIPLE SCLEROSIS?
    Racz Lilla
    Berenyi Ervin
    Barsi Peter
    Bernath David
    Csepany Tunde
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2017, 70 (7-8): : 275 - 283
  • [37] Effect of immunomodulatory treatment of multiple sclerosis on lymphocyte surface immunomarkers
    Michalowska-Wender, G
    Losy, J
    Wender, M
    Januszkiewicz-Lewandowska, D
    Nowak, J
    POLISH JOURNAL OF PHARMACOLOGY, 2003, 55 (05): : 877 - 880
  • [38] Immunomodulatory networks in multiple sclerosis
    Ntranos, Achillefs
    Lee, Brian
    Xie, Hui
    Rockoff, Jonathan
    Brandstadter, Rachel
    Kim-Schulze, Seunghee
    Lublin, Fred
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [39] Immunomodulatory therapy of multiple sclerosis
    Weber, F
    NERVENHEILKUNDE, 2000, 19 (06) : 310 - 315
  • [40] Treatment Issues in Multiple Sclerosis in Latin America
    Vizcarra-Escobar, Darwin
    Mendiola-Yamasato, Andrea
    Anculle-Arauco, Victor
    Vizcarra-Pasapera, Joaquin
    Guillen-Mendoza, Daniel
    NEUROEPIDEMIOLOGY, 2015, 44 (01) : 66 - 68
12345